Search results for: 'learning ad development'
- Related search terms
- development startup and future trend of ophthalmic drugs market
- development states and future trend of ophthalmic drugs market
- development startup ad future trend of ophthalmic drugs market
- learning and development sales market
- learning ad development sales market
-
19 Sep 2018  |  North America  |  Market Research
Global Biologics Contract Development and Manufacturing Organization (CDMO) Market, Forecast to 2022
Investments in Single Use/Disposable Technologies to Capitalize on Growth Opportunities in High-value Low-volume Biologics
The global pharmaceutical industry is evolving with the rising need for novel therapies in the changing disease landscape. As a result of rising prevalence of chronic infectious diseases as well as growing cancer incidence, market needs are shifting from traditional small molecules to large molecules. This study presents an overview of the global b...
$4,950.00
Special Price $3,712.50 save 25 %
-
12 Apr 2018  |  Europe  |  Market Research
Global Biologics Contract Development & Manufacturing Organization (CDMO) Market—Companies-to-Action
Establishment of Need-based Business Models with Advancements in Manufacturing Techniques is Driving Market Growth
The study on the "Global Biologics Contract Development & Manufacturing Organizations (CDMO) Market: Companies-to-Action" presents an overview of the global biologics development and manufacturing landscape with an emphasis on the seven leading CDMOs in the market. The study highlights the shifting focus and investments of bio-pharma companies towa...
$3,000.00
Special Price $2,250.00 save 25 %
-
28 Dec 2018  |  Global  |  Technology Research
RNA Technologies Enabling Drug Discovery and Development
Redefining the Future of Healthcare through Groundbreaking RNA Therapies
This research service encompasses a comprehensive analysis of RNA therapy industry from the following perspectives: • Industry Drivers and Challenges • Technology Snapshot and Trends • Clinical Pipeline Analysis • Overview of the IP Landscape • Innovator Profiles • Future Roadmap The RNA therapy platforms covered include: • Splice-Switching Oligon...
$4,950.00
Special Price $3,712.50 save 25 %
-
13 Nov 2018  |  Global  |  Technology Research
Artificial Intelligence Revolutionizing the Pharmaceutical Industry
Optimal Synergy Between Leading-edge Computational Science and Therapeutics Development
The impressive advances in life sciences research and development (R&D) befallen in the past two-three years are playing a leading role in the transformation of the healthcare industry. A myriad of new developments in the fields of gene and cell therapies, empowered with nanotechnology advances, omics technologies and novel smart molecules approach...
$4,950.00
Special Price $3,712.50 save 25 %
-
21 Aug 2018  |  Global  |  Market Research
Artificial Intelligence for Medical Image Analysis—Companies-to-Action, 2018
Lay of the Land, Growth Opportunities and Future Direction
Medical imaging has become the bellwether application for artificial intelligence (AI) technologies in healthcare. From deep learning and machine learning approaches, to cognitive computing, to even natural language processing, several AI approaches are now being incorporated in the field of radiology. Apart from academic research groups, almost al...
$3,000.00
Special Price $2,250.00 save 25 %
-
29 Dec 2018  |  Global  |  Technology Research
Digital Pathology: Roadmap to the Future of Medical Diagnosis
Digital Pathology solutions and Artificial Intelligence tools are destined to transform efficiency and workflow of Pathology services
Digital Pathology encompasses the use of optmized pathology workstations, whole slide imaging, image analysis, image management, laboratory information management system, use of machine learning, data handling and storage. Pathology is one of the most important fields in medicine, as the service provides investigation and validation platform in lie...
$4,950.00
Special Price $3,712.50 save 25 %
-
01 Aug 2018  |  Europe  |  Market Research
France Digital Dental Solutions Market, Forecast to 2020
Improving Accuracy and Workflow Efficiency Driving Demand for Digital Dental Solutions
Dental practices and dental laboratories in France have recognised the importance of adopting digital dental solutions. Digital dental solutions continue to see substantial growth, and are expected to continue expanding in the market, as business models and significant value offerings keep evolving in tandem with the fast-paced world of connected h...
$1,500.00
Special Price $1,125.00 save 25 %
-
16 Feb 2018  |  Europe  |  Market Research
Poland’s New Business Models in Medical Imaging, Forecast to 2021
A Change of Course in Polish Healthcare Policy May Disrupt Conventional Public-Private Working Models
This research study focuses on the drive to operationalize capital and service costs favoring non-conventional business models (MES and MVS) in Poland over traditional capital-intensive purchasing and service models. The study also features a detailed elaboration on the legacy of public-private partnerships (PPP), framework agreement case studies, ...
$4,950.00
Special Price $3,712.50 save 25 %
-
28 Sep 2018  |  North America  |  Technology Research
Gene Editing and Gene Therapy Breakthroughs to Propel Mainstream Disease Treatments
A new wave of gene therapies is set to revolutionize treatments over the next decade for inherited diseases which are either untreatable or which do not have a satisfactory treatment outcome at present
The drug approvals of Yescarta (axicabtagene ciloleucel), Luxturna (Voretigene neparvovec) and Kymriah (Tisagenlecleucel) have turned a leaf in the pharmaceutical chapter of gene therapy development. Currently, genetic disorders do not have satisfactory treatment outcomes. This is in part due to the inability of small molecule drugs and enzyme repl...
$4,950.00
Special Price $3,712.50 save 25 %
-
10 Jan 2018  |  Asia Pacific  |  Market Research
APAC Biosimilar Market, Forecast 2025
Patent Expiries, Defined Regulatory Pathways, and Escalating Healthcare Costs to Boost Growth
Biosimilars is a massive opportunity; regardless of a slow start, the market will eventually be a huge business. As per Frost & Sullivan’s estimate, biologic drugs worth $70–$80 billion will lose exclusivity in the next 5 years globally and APAC’s contribution would be more than 20%. Countries in the region, such as India, China, and South Korea, o...
$4,950.00
Special Price $3,712.50 save 25 %